Q2 2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Jincheng Pharma(300233) the Revenue is 696.82 M (+9.16%);the EBIT is 47.28 M (+609%);the EPS is 0.222 (+963.9%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.70B9.16%
----
----
EBIT
0.05B609.03%
----
----
EPS
0.2219963.90%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf